Prevalence of Toxoplasma Gondii in Patients with Schizophrenia and Its Association with Clinical Symptoms

Abstract

Background: Schizophrenia is a multifactorial neuropsychiatric disorder influenced by both genetic predisposition and environmental factors. Recent evidence suggests a possible link between latent Toxoplasma gondii infection and schizophrenia, though the underlying mechanisms remain unclear. Objective: To compare the seroprevalence of T. gondii in patients with schizophrenia and healthy individuals, and to evaluate the relationship between seropositivity and clinical parameters. Methods: A total of 265 participants (155 schizophrenia patients and 110 healthy controls) were enrolled. IgG and IgM antibodies were detected using electrochemiluminescence immunoassay (ECLIA), avidity was assessed using ELISA, and DNA presence was tested with real-time PCR. Clinical symptoms were evaluated using the Brief Psychiatric Rating Scale (BPRS). Statistical analysis included logistic regression and non-parametric tests (p < 0.05). Results: T. gondii IgG seropositivity was significantly higher in schizophrenia patients (29 %) than in controls (18.2 %) (p = 0.044, OR = 1.84; 95 % CI: 1.01-3.34). IgM positivity and DNA detection did not differ significantly. All seropositive participants showed high IgG avidity, indicating latent infection. BPRS scores and illness duration were higher in IgG-positive individuals, but the differences were not significant. Conclusion: Latent T. gondii infection may be associated with schizophrenia. However, further multicenter studies integrating molecular and serological approaches are needed to clarify its role in disease pathogenesis.